483
Halo Pharmaceutical Canada IncHalo Pharmaceutical Canada Inc – FDA 483, Nov 14, 2014
Record Details
Halo Pharmaceutical Canada Inc. in Mirabel, Quebec, a contract drug manufacturer, was cited for multiple deficiencies during an FDA inspection from November 10-14, 2014. Key issues included inadequate laboratory controls for test procedures, incomplete out-of-specification investigations, and failures in labeling inspection, change control, and material storage procedures. These observations indicate significant concerns with quality control and adherence to established procedures.
View Company Profile
ID · a4ed44d4-b5fe-4334-8564-aaf9310152b1
Other documents for Halo Pharmaceutical Canada Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.